Business & Industry
Sino BioPharm to Acquire LaNova Medicines for $950.9 M Deal
LaNova Medicines, which happens to be a cancer drugmaker that previously licensed medicines to AstraZeneca as well as Merck & Co., has gone on to...
News
Rheumatoid Arthritis Treatment with Genetic Link Adds Hope
Researchers at the University of Edinburgh have gone on to identify a genetic link that could revolutionize rheumatoid arthritis treatment. This discovery now opens the...
News
Sleep Lean Reviews – Is It Effective for Weight Loss?
Sleep Lean is a dietary supplement formulated for people who want to enhance deep sleep and support healthy weight loss. Designed as a dual-action formula,...
Clinical Trials
CDSCO Moves to Online Submission for CGTP Trial Applications
As part of its continued efforts to streamline operations through digitisation, the Central Drugs Standard Control Organisation (CDSCO) has transitioned from offline to online acceptance...
News
Singapore Seeking Pharmaceutical Tariff Concessions from US
The deputy prime minister and trade minister of Singapore, Gan Kim Yong, has announced his plans to visit Washington this July in order to negotiate certain...
News
Merck to Acquire Verona for $10B, COPD Drug in Focus
Merck has pulled off another acquisition that happens to fit in its sweet spot, says Rob Davis, its CEO. As Merck acquires Verona Pharma after...
News
PDUFA Crucial for Biopharmaceutical Innovation in the US
The United States happens to lead the world when it comes to the discovery and development of innovative medicines. All thanks largely to a regulatory...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.